BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Mdm2 p53 binding protein homolog (MDM2; HDM2); fragile X mental retardation 1 (FMR1)

May 19, 2016 7:00 AM UTC

Mouse studies suggest the MDM2 inhibitor nutlin-3 could help treat fragile X syndrome. In the FMR1-knockout mouse model of fragile X, activation and proliferation of neural stem cells (NSCs) in the de...